Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGNX
#4879
REGENXBIO Inc. - Common Stock
0.0
7
USD
-98.98%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-98.98%
Monthly Change
-99.19%
6 month change
-99.46%
Year Change
-99.48%
Previous Close
6.8
9
Open
0.0
7
Low
0.0
7
High
0.0
7
Volume
100
Markets
US Stock Market
Healthcare
RGNX
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
42.5 M
42.95 M
43.46 M
44.43 M
50.09 M
51.61 M
51.7 M
Valuation ratios
Enterprise value
1.59 B
1.06 B
870.11 M
780.28 M
329.64 M
708.76 M
317.29 M
Price to earnings ratio
-15.22
11.24
-3.42
-3.05
-1.68
-3.83
-1.15
Price to sales ratio
10.94
3.05
8.52
8.89
4.89
4.36
3.78
Price to cash flow ratio
-31.28
6.56
4.63
3.67
2.21
-5.99
-1.43
Price to book ratio
4.48
1.88
1.86
2.57
1.47
7.23
0.67
Enterprise value to EBITDA ratio
-13.21
6.87
-3.25
-2.9
-1.42
-4.25
-1.21
Profitability ratios
Return on assets %
-0.16
0.11
-0.34
-0.46
-0.49
-0.43
-0.26
Return on equity %
-0.29
0.17
-0.54
-0.85
-0.87
-1.89
-4.27
Return on invested capital %
-226.49
126.79
-177.57
-257.21
-402.58
-257.59
—
Gross margin %
71.93
89.53
51.61
58.76
67.66
100
100
Operating margin %
-77.14
34.01
-233.2
-297.12
-264.18
-94.58
-1 303.96
EBITDA margin %
-77.84
32.77
-237.38
-297.88
-263.21
-97.79
-1 317.71
Net margin %
-71.98
27.18
-248.68
-291.99
-257.11
-113.75
-1 408.59
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.52
3.98
3.19
2.57
2.69
2.38
2.62
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.26
0.52
0.12
0.13
0.17
0.38
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-1.45
4.98
-4.81
-4.99
-3.5
-2.4
-4.51
EBIT per share
-3.2
3.64
-6.09
-6.13
-4.81
-3.13
-4.95
EBITDA per share
-3.23
3.51
-6.2
-6.15
-4.7
-3.23
-5.05
Total debt per share
—
—
—
—
—
—
—
Cash per share
14.02
19.34
13.1
7.18
4.95
4.67
2.87
Net current asset value per share
14.25
11.81
9.64
7.66
5.62
5.45
3.56
Tangible book value per share
10.13
17.4
11.96
7.13
5.24
1.99
0.4
Working capital per share
12.06
8.84
6.62
4.68
3.53
3.16
2.2
Book value per share
10.13
17.4
11.96
7.13
5.24
1.99
0.4
News
REGENXBIO Inc. (RGNX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
REGENXBIO: 'Hold' On RGX-121 CRL MPS II And RGX-202 DMD Results (NASDAQ:RGNX)
REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript
Regenxbio (RGNX) Reports Q1 Loss, Lags Revenue Estimates
EyePoint (EYPT) Reports Q1 Loss, Tops Revenue Estimates
OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
OCGN Gene Therapy Pipeline: Key 2026-27 Catalysts Ahead
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval
OCGN Gene-Agnostic Eye Therapy Could Shift Retinal Drug Development
OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch